| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.04 |